-
Tobramycin: From Ribosome to Translation
2026-09-15
A translational perspective on Tobramycin that connects 30S ribosome engagement, historical susceptibility evidence, resistance research, assay design, and practical reagent strategy for modern microbiology teams.
-
Anlotinib Hydrochloride: Angiogenesis Assay Guide
2026-09-15
Build quantitative angiogenesis and cancer research workflows around a multi-target tyrosine kinase inhibitor that links receptor phosphorylation to endothelial behavior. This guide covers dose design, migration and tube assays, translational interpretation, and practical troubleshooting.
-
Verapamil HCl: A Txnip-to-Phenotype Workflow
2026-09-14
Verapamil HCl is more than an L-type calcium channel blocker: it is a useful perturbation tool for connecting calcium signaling with Txnip, bone turnover, apoptosis, and inflammation. This article translates recent osteoporosis findings into practical assay and interpretation strategies.
-
In Vitro Drug Response: Beyond Relative Viability
2026-09-14
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that growth inhibition and cell death are related but non-equivalent components of an anticancer response. The framework supports more precise interpretation of in vitro drug experiments by separating cytostatic effects, killing, and their different temporal patterns.
-
A-1210477: A Causal MCL-1 Apoptosis Probe
2026-09-13
Explore how the MCL-1 inhibitor A-1210477 can function as a causal probe of mitochondrial apoptosis rather than merely a cytotoxic reagent. This article connects MCL-1 biology, BAX/BAK-dependent tumor control, assay design, compound handling, and interpretation limits for rigorous cancer research.
-
Tivozanib: Interpreting VEGFR Drug Responses
2026-09-12
Tivozanib (AV-951) is a highly selective VEGFR inhibitor, but potency alone cannot explain its cellular effects. This guide shows how to pair pathway, viability, and cell-death measurements for more rigorous anti-angiogenic therapy research.
-
Ultrafiltration for Circular RNA Purification
2026-09-12
Guillen-Cuevas and colleagues evaluated ultrafiltration as a scalable way to separate protein-encoding circular RNA from linear precursor and nicked RNA contaminants. By analyzing membrane sieving and critical flux, the study achieved higher reported purity and comparable yield than size-exclusion HPLC, supporting ultrafiltration as a promising research-scale purification strategy.
-
Carbapenemase Transmission in Enterobacter cloacae
2026-09-11
Chen et al. profiled 54 carbapenem-resistant Enterobacter cloacae isolates from eight Guangdong teaching hospitals, combining gene localization, susceptibility testing, conjugation, mobile-element analysis, and ERIC-PCR typing. The study found plasmid-associated blaNDM-1, high transferability, multidrug resistance, and evidence for both clonal and horizontal dissemination, providing a practical framework for hospital resistance surveillance.
-
Tauroursodeoxycholic Acid: ER Stress Workflow
2026-09-11
Tauroursodeoxycholic Acid, or TUDCA, gives researchers a practical small-molecule way to reduce ER stress, stabilize mitochondria, and interrogate apoptosis. This workflow translates findings from subarachnoid hemorrhage research into controlled assay design for neuroinflammation, metabolic disorder studies, and other stress-sensitive models.
-
GW 4869 Hydrochloride Hydrate and Exosome Causality
2026-09-10
A translational framework for using GW 4869 hydrochloride hydrate to test whether neutral sphingomyelinase-dependent extracellular vesicle release is causally linked to lithium-enhanced osteogenesis, with guidance on controls, interpretation, and experimental readiness.
-
Acridine Orange hydrochloride: Practical Staining Guide
2026-09-10
Acridine Orange hydrochloride provides membrane-permeable, differential fluorescence for nucleic acid staining, supporting cell cycle analysis, apoptosis detection, and flow-based DNA/RNA profiling. This guide covers product specifications, preparation, QC, and troubleshooting while noting that it is not intended for non-nucleic-acid targets or long-term storage of prepared solutions.
-
Doxorubicin: Designing Interpretable Cell Assays
2026-09-09
Doxorubicin and Adriamycin are powerful DNA-damaging tools, but viability loss alone can obscure their biological effects. This guide presents a state-aware assay framework that separates cytotoxicity, apoptosis induction in cancer cells, growth arrest, and phenotype remodeling for more reliable cancer research.
-
Pexmetinib (ARRY-614): Reading p38 Signaling
2026-09-09
Pexmetinib (ARRY-614) is more than a dual kinase inhibitor: it can serve as a mechanistic probe for linking p38 signaling, Tie2 biology, and cytokine output. This article presents a phosphatase-aware framework for designing and interpreting assays in inflammation and myelodysplastic syndromes research.
-
Substrate Stiffness, LAMB1–FAK, and Dentinogenesis
2026-09-08
This study identifies a mechanotransduction pathway in which substrate stiffness promotes odontoblast-like cell spreading and dentinogenic differentiation through a LAMB1–FAK–MEK1/2 axis. Its combination of tunable PDMS substrates, mineralization assays, gene-expression analysis, and protein-interaction studies provides a useful framework for connecting biomaterial mechanics with reparative dentin formation.
-
2D and 3D Radiosensitizer Screening in Lung Cancer
2026-09-08
Ramirez Parra and colleagues compared DNA-PKcs, ATR, PARP, and IAP inhibition across matched 2D and 3D lung cancer models to determine how culture context affects radiosensitizer ranking. The study shows that ATR and DNA-PKcs inhibition produced the most consistent effects, while 3D extracellular-matrix assays added biologically relevant context without uniformly overturning 2D results.